Viatar CTC Solutions to Present at Aegis Capital 2015 Growth Conference

LOWELL, MA--(Marketwired - Oct 7, 2015) - Viatar CTC Solutions, Inc. (OTCQB: VRTT), a medical technology company focused on the treatment of patients with metastatic cancer, today announced that Ilan Reich, Chairman and Chief Executive Officer, will present a corporate overview at the Aegis Capital 2015 Growth Conference held at the Encore at Wynn in Las Vegas from October 7-9, 2015. 

Mr. Reich will present on Thursday October 8, 2015 at 1:30 pm PT. A live webcast of the presentation will be available at http://wsw.com/webcast/aegis2/vrtt. For those who are not available to listen to the live webcast, a replay will be archived for 90 days on Viatar's website at http://www.viatarctcsolutions.com/investors/.

About Viatar CTC Solutions

Viatar CTC Solutions Inc. is a medical technology company focused on the treatment of patients with metastatic cancer. The company's lead product, the Viatar™ Therapeutic Oncopheresis System, removes circulating tumor cells from whole blood using label-free cross-flow filtration. Pending regulatory approval targeted for 2016, it will be used as a periodic therapy to improve overall survival for a wide range of solid tumor types such as lung, breast, colon, prostate and gastric cancers.

This proprietary technology also powers the company's liquid biopsy products, which are collection systems for use by genetic testing companies, researchers and medical oncologists that provide a greater quantity and purity of circulating tumor cells for their molecular analysis and personalized medicine objectives.